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A B S T R A C T
Quinones are common in nature, and often cytotoxic. Their proposed toxicity mechanisms involve redox cycling
with radical generation, and/or reactions with nucleophiles, such as protein cysteine (Cys) residues, forming
adducts via Michael addition reactions. The selenenyl anion of selenocysteine (Sec) is a stronger nucleophile,
more prevalent at physiological pH, and more reactive than the corresponding thiolate anion of Cys. We
therefore hypothesized that Sec residues should be readily modiﬁed by quinones and with potential con-
sequences for the structure and function of selenoproteins. Here, we report data on the interaction of p-ben-
zoquinone (BQ) with the selenoprotein thioredoxin reductase-1 (TrxR1), which exposes an accessible Sec residue
upon physiological reduction by NADPH. Our results reveal that BQ targets NADPH-reduced TrxR1 and inhibits
its activity using 5,5′-dithiobis(2-nitrobenzoic acid) or juglone as model substrates, consistent with the targeting
of both the Cys and Sec residues of TrxR1. In the absence of NADPH, BQ modiﬁed the non-catalytic Cys residues,
leading to subunit crosslinking, mainly through disulﬁdes, which also resulted in some loss of activity. This
crosslinking was time-dependent and independent of the Sec residue. Addition of NADPH after BQ pre-treatment
could resolve the disulﬁde-linked crosslinking. TrxR activity loss was also observed upon incubation of
J774A.1 cells or cell lysates with BQ. These data suggest that BQ readily targets TrxR1, albeit in a rather complex
manner, which results in structural changes and loss of enzyme activity. We suggest that TrxR1 targeting can
explain some of the cytotoxicity of BQ, and potentially also that of other quinone compounds.
1. Introduction
Quinones are ubiquitous in nature and can be found in many natural
products, endogenous chemicals (e.g. dopaquinone, estrogen-derived
quinones) and environmental contaminants (e.g. naphthoquinone), or
generated via the metabolism of aromatic hydrocarbons (e.g. benzene,
hydroquinones), drugs (e.g. acetaminophen, geﬁtinib) and some food
constituents (e.g. phenols/polyphenols) [1]. Thus, quinone exposure
can occur endogenously, pharmacologically, via the diet, and via en-
vironmental pollutants. The inherent reactivity of quinone compounds
has been associated with toxicity. Speciﬁc examples include the hy-
droxyaniline metabolite of geﬁtinib that further undergoes two-electron
oxidation to produce a reactive quinine imine intermediate, which is
associated with hepatotoxic side eﬀects [2]. The hepatotoxicity of
acetaminophen involves its liver-speciﬁc metabolite N-acetyl-p-benzo-
quinone imine (NAPQI) that mediates protein modiﬁcations, lipid oxi-
dation, and calcium homeostasis changes [3]. It also targets the sele-
noprotein thioredoxin reductase (TrxR), which is likely to contribute to
toxicity [4,5].
Two major characteristics have been demonstrated to account for
quinone toxicity (reviewed in Refs. [1,6]). They readily undergo one-
electron reduction to give semiquinone radical anions, with the latter
rapidly undergoing electron transfer to O2 to give O2−., and subse-
quently H2O2 (via dismutation), and hydroxyl radicals in the presence
of trace metal ions. Alternatively, quinones are Michael acceptors, and
can therefore modify proteins and/or DNA at nucleophilic sites by
forming covalent adducts [7,8]. Our previous research have demon-
strated that cysteine (Cys) is kinetically a favoured site for quinone
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adduction, and the modiﬁcation of Cys residues in protein can further
lead to the protein structure changes and dysfunction [9,10].
Selenocysteine (Sec, U), the sulfur-for-selenium substituted ana-
logue of Cys, has a relatively low pKa (5.2, compared to 8.3 for Cys) and
is generally much more reactive with electrophiles than Cys [11].
Considering the highly polarizable nature of Sec, the exact pKa value
may have a broader range, and is dependent on the microenvironment.
A previous study has reported a pKa value of Sec in a peptide as low as
to 3.3 [12]. Thus, under physiological condition, Sec residues will be
almost completely ionized to the selenolate, unlike most Cys residues,
giving Sec a higher nucleophilicity, a higher susceptibility to electro-
philic attack, and a better leaving group character [13]. Therefore, we
hypothesized that quinone compounds should rapidly react with Sec
residues of selenoproteins.
Selenoproteins are often, but not always, oxidoreductases that have
Sec as a catalytic residue. This is typically positioned close to the C-
terminus, such as in TrxR, or within a Trx fold, such as in glutathione
peroxidases (GPxs) [14]. The catalytic cycle of many selenoproteins
involves selenolate/selenenylsulﬁde exchange reactions, analogous to
thiolate/disulﬁde reactions [15]. For TrxR, the three critical motifs for
its function are an enzyme-bound FAD, an N-terminal -CVNVGC- di-
thiol/disulﬁde motif, and a C-terminal Sec-containing -GCUG-tetra-
peptide [16,17]. The proposed mechanism of TrxR involves the electron
transfer from nicotinamide adenine dinucleotide phosphate hydrogen
(NADPH) via FAD and the N-terminal motif to the C-terminal -GCUG-
sequence [17,18]. Previous studies have demonstrated that certain
quinone compounds can be substrates for, as well as inhibitors of TrxR,
which may trigger cellular events and Nrf2 activation, as reviewed
elsewhere [19]. The enzyme can use either the N-terminal FAD/dithiol/
disulﬁde or the C-terminal Sec-containing motif to directly catalyse
mixed one- or two-electron reduction reactions with quinones, de-
pending upon the quinone structures [20]. The reduction of most of the
quinones tested to date seems to require the Sec residue, whilst re-
duction of 5-hydroxy-1,4-naphthoquinone (juglone) also displays a Sec-
independent redox cycling reaction with the enzyme [20–23]. The
catalytic mechanisms of TrxR isoforms are also diﬀerent, as when
compared to cytosolic TrxR1, mitochondrial TrxR2 has a higher sub-
strate selectivity and lower catalytic eﬃciency. Thus, Sec deletion in
the C-terminal motif of TrxR2 does not inﬂuence reduction of either
DTNB or juglone as much as with TrxR1 [24].
The highly-reactive and solvent-accessible Sec residue of TrxRs
makes the enzyme readily modiﬁable by electrophilic compounds.
Thus, previous studies on isolated TrxR1, or mixtures of TrxR isoforms
(non-fractionated materials) have provided evidence for inhibition by
cisplatin [25], dinitrohalobenzenes [26], curcumin [27], and some
ﬂavonoids [28], with this typically resulting in enzyme inactivation. As
p-benzoquinone (BQ), the main metabolite of benzene, has been shown
to react directly with Cys residues in glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) and creatine kinase (CK), resulting in the en-
zyme inactivation and crosslink formation [10], we hypothesized that
similar reactions would occur with the major cellular TrxR isoform,
cytosolic TxrR1. TrxR1 predominantly exists as a non-covalently linked
homodimer [17,29], though higher oligomers have also been reported
[30]. Oxidation of the Trp114 residue of TrxR1 can also lead to di-
Trp114 covalently linked subunits aggregating into tetramers, with this
decreasing enzyme activity [31].
Here, we investigated direct covalent interactions of BQ with TrxR1,
related enzyme activity changes, and the role of NADPH-mediated re-
duction of TrxR1 in these interactions. Furthermore, we identiﬁed the
occurrence of quinone-induced and disulﬁde-linked TrxR1 dimers, and
determined that BQ exposure inhibits TrxR activity in both intact
J774A.1 cells and corresponding cell lysates. Overall, this study pro-
vides novel data on covalent interactions of BQ with TrxR1, with po-
tential biological importance with regards to the mechanisms under-
lying BQ toxicity.
2. Materials and methods
2.1. Reagents
Thioredoxin reductase 1 (TrxR1) from rat and human point-mutated
TrxR1 species (in which Sec is mutated to Cys or Ser) were prepared
according to previously reported methods [17,32,33]. Reduced glu-
tathione (GSH), 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), nicotina-
mide adenine dinucleotide phosphate hydrogen (NADPH), biotin
polyethyleneoxide iodoacetamide (BPI), 5-hydroxy-1,4-naphthoqui-
none (juglone), 9,10-phenanthrenequinone (9,10-PQ), auranoﬁn and p-
benzoquinone (BQ) were purchased from Sigma (St. Louis, MO, USA).
BQ, juglone and 9,10-PQ was prepared freshly for every experiment by
dissolving these in dimethyl sulfoxide (DMSO) to give stock solutions,
with these then diluted into the relevant reaction systems. All other
reagents were of highest possible quality. High purity (MQ) water was
obtained from a Milli-Q System (Millipore, Bedford, MA).
2.2. Enzyme activity measurements
TrxR1 activity was determined using two diﬀerent model substrates,
DTNB and juglone [21,34]. Activity measurements were performed
with DTNB (1mM) or juglone (400 μM) in 50mM Tris-HCl (pH 7.6),
2 mM EDTA, and 200 μM NADPH. The reduction of DTNB to form TNB-
was quantiﬁed through absorbance increases at 412 nm. Alternatively,
TrxR1 activity was quantiﬁed by following the oxidation of NADPH to
NADP+ as a decrease in absorbance at 340 nm, with this monitored at
10 s intervals over a 5min period. As there are other DTNB-reactive
groups in cell lysates, the TrxR inhibitor auranoﬁn (500 nM) was added
into the reaction system as a background control, with the absorbance
changes in the presence of this inhibitor used to correct the experi-
mental values from the cell lysates when using DTNB as the substrate.
2.3. Inactivation of TrxR1 by BQ in puriﬁed protein
BQ (4 and 100 μM) was incubated with TrxR1 (0.8 μM) for 5min in
50mM Tris-HCl (pH 7.6) containing 2mM EDTA at 22 °C. Samples were
then desalted using Zeba column (Thermo, Waltham, MA, USA) and
remaining enzyme activity was measured using the method described
above.
2.4. Inactivation of TrxR by BQ in J774A.1 cells
Murine macrophage-like J774A.1 cells were cultured in Dulbecco's
modiﬁed Eagle's medium (DMEM, Sigma) containing 10% (v/v) fetal
bovine serum (Invitrogen), and 2mM L-glutamine (Thermo, Waltham,
MA), at 37 °C in a humidiﬁed atmosphere of 5% CO2.
For cell lysate preparation, cells were seeded in cell culture ﬂask at a
density of 1×106 cell mL−1. After growth to conﬂuence, the cells were
collected by centrifugation, washed twice with warm phosphate-buf-
fered saline (PBS), and lysed in phosphate-buﬀered solution (50mM,
pH 7.4) containing 10mM EDTA on ice. The lysates were then cen-
trifuged at 14000 g for 5min to remove debris, and the supernatants
taken for experiments. Protein concentrations were determined using
the bicinchoninic acid (BCA) assay (Sigma, St. Louis, MO, USA). The
cell lysates were incubated with BQ (0–80 μM) for 5min, and residual
TrxR activity determined using the method described above.
For intact cell experiments, J774A.1 cells in culture were incubated
with BQ (0–80 μM) for 5min. Before harvesting, the cells were washed
twice with PBS, and the cells then lysed in phosphate-buﬀered solution
(50mM, pH 7.4) containing 10mM EDTA on ice. The lysates were
centrifuged at 14000 g for 5min, and the supernatants taken to de-
termine TrxR activity. The total protein concentration was quantiﬁed
using the BCA assay.
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2.5. Kinetic parameter determination
TrxR1 (0.8 μM) was incubated with BQ (5–100 μM) in the presence
of NADPH (200 μM) in 50mM Tris-HCl (pH 7.6) containing 2mM EDTA
at 22 °C. Activity was monitored at 340 nm in 10 s intervals over a 5min
period, as described above, with the concentrations of NADPH con-
sumed determined using a standard curve over the range 100–200 μM;
kcat and Km values were calculated by Michaelis-Menten ﬁtting using
OriginPro 2016 (OriginLab, Northampton, MA, USA).
2.6. Assessment of dimer formation associated with BQ treatment
TrxR1 (0.8 μM) was incubated with BQ (0.8–100 μM) for 5min in
the presence or absence of NADPH (200 μM) at 22 °C, and 18 μL samples
were removed, with these then diluted with loading buﬀer with or
without DTT (50mM). Samples were loaded on to 15-well SDS-PAGE
gels (4–12% Bis-Tris Gel, Invitrogen) and run using NuPAGE MES SDS
running buﬀer (Invitrogen) at 200 V for 25min. The proteins were
subsequently stained with Coomassie blue and scanned using a Gel
Documentation system (Bio-Rad, Hercules, CA, USA).
2.7. Visualisation of BQ-modiﬁcations using BPI labelling
TrxR1 (0.8 μM) were incubated with BQ (0.8–100 μM) for 5min at
22 °C. After incubation, 1 μL of sample was taken and mixed with 19 μL
of BPI (100 μM) at pH 6.5 or 8.5, followed by further incubation at 37 °C
in the dark for 30min to alkylate remaining free -SH and -SeH groups in
the enzyme [27]. Samples (18 μL) were then diluted with loading
buﬀer, and subjected to SDS-PAGE (15 well, 4–12% Bis-Tris Gels, In-
vitrogen) using NuPAGE MES SDS running buﬀer (Invitrogen) at 200 V
for 25min. The separated proteins were transferred to PVDF mem-
branes using an iBlot 2 dry blotting system (Thermo, Waltham, MA) at
20 V for 7min. The BPI-labelled protein was then detected using
horseradish peroxidase-conjugated streptavidin and enhanced chemi-
luminescence detection.
2.8. Statistics
Results were analysed using one-way analysis of variance (ANOVA)
followed by Tukey's post hoc test using SPSS 25 (IBM, Armonk, NY,
USA). Data were presented as mean ± standard deviations (SD) from
at least three independent experiments unless otherwise noted.
Signiﬁcance was set at p < 0.05.
3. Results
3.1. BQ-induced inhibition of TrxR1 enzyme activity
BQ was previously found to be a substrate of TrxR [20], and here we
determined the enzymatic parameters for this reaction, with kcat de-
termined as 7.44 ± 0.14 s−1 and kcat/Km 0.91 ± 0.22 μM−1s−1
(Supplementary Fig. 1), in good agreement with the earlier determi-
nations of kcat 4.8 ± 0.5 s−1 and kcat/Km 0.39 ± 0.1 μM−1s−1 [20],
when also considering the higher speciﬁc activity of the recombinant
TrxR1 used in this study [33].
As shown in Fig. 1, incubation of BQ with TrxR1 induced a rapid
and concentration-dependent irreversible enzyme activity loss in the
presence of NADPH, as noted earlier for DTNB reduction [20], and here
with both DTNB and juglone as substrates. Reduction of DTNB requires
the intact, and fully reduced, Cys and Sec residues of the C-terminal
tetrapeptide, while juglone reduction can proceed independently of the
Sec residue in TrxR1 [21]. Therefore, the decreased reduction of both
substrates, as determined here, is consistent with the targeting, by BQ,
of residues in both the C-terminal and N-terminal catalytic centres of
TrxR1. Moreover, in absence of NADPH, incubation with BQ also in-
duced enzyme activity loss, especially using juglone as the substrate,
though the extent of this inhibition was less pronounced.
3.2. BQ-induced modiﬁcation of Cys and Sec residues in TrxR1
Previous reports have demonstrated that BPI can alkylate speciﬁc
residues in proteins, with the selectively of this process determined by
the pH of the reaction medium during the derivatization reaction
[27,35]. At high pH values (e.g., pH 8.5), both free -SH and -SeH groups
are alkylated, while at lower pH values (e.g., pH 6.5) the -SeH group is
predominantly alkylated due to the lower pKa value of Sec compared to
Cys.
Here, BQ-induced TrxR1 modiﬁcations were analysed by BPI la-
belling of free -SH and -SeH residues at these diﬀerent pH values. As
shown in Fig. 2A, treatment of TrxR1 with BQ for 5min in the absence
of NADPH lowered the extent of BPI labelling of the enzyme to a similar
extent at both pH 6.5 and pH 8.5. In the presence of NADPH, but ab-
sence of BQ, BPI labelling of TrxR1 was clearly increased, reﬂecting
NADPH-dependent exposure of the catalytic Cys and Sec residues,
compatible with the notion that these residues are shielded by disulﬁde
and selenenylsulﬁde motifs in the absence of NADPH [17]. This label-
ling was eﬃciently blocked in the presence of 100 μM BQ, suggesting
that BQ competes with BPI for reaction with the catalytic Cys and Sec
residues of the NADPH-reduced enzyme (Fig. 2B). These results col-
lectively suggest eﬃcient modiﬁcation, by 100 μM BQ, of non-catalytic
Cys residues in TrxR1 in the absence of NADPH, and both the catalytic
Cys and Sec residues in the presence of NADPH.
3.3. BQ-induced covalent TrxR1 crosslinks
Incubation of BQ (0–100 μM) with TrxR1 (0.8 μM) also induced
covalent crosslinks between TrxR1 subunits in a concentration-depen-
dent manner. In the absence of NADPH, treatment with 100 μM BQ
triggered a dramatic increase in multimeric TrxR1 bands (Fig. 3A). DTT
could reduce the majority of these crosslinks, consistent with the pre-
sence of disulﬁde-bonded multimers (Fig. 3B). This implies that some of
the BQ-dependent blockage of BPI labelling (Fig. 2) is due to formation
of these species. In the presence of NADPH, no obvious disulﬁde-linked
dimers were observed.
The BQ-induced TrxR1 crosslink formation also occurred in a time-
dependent manner. Whilst disulﬁde bond formation occurred im-
mediately after the reactions were initiated, non-reducible dimers were
detected with reaction times greater than 5min (Fig. 3C). This crosslink
formation was independent of the presence of the catalytic Sec residue,
as mutation of Sec to either Cys or Ser did not aﬀect this BQ-induced
TrxR1 dimerization (Fig. 3D and E).
3.4. NADPH-mediated protection from BQ-induced TrxR1 crosslinks
The role of NADPH in modulating the formation of BQ-induced
TrxR1 subunit crosslinks was investigated by either co-incubation with
NADPH, or addition of NADPH after TrxR1 pre-exposure to BQ. As
shown in Fig. 4A, co-incubation with NADPH could concentration-de-
pendently protect TrxR1 against dimerization, with NADPH con-
centration greater than two-fold over the BQ concentration eliminating
disulﬁde-bonded dimer formation.
Adding NADPH after pre-exposure of TrxR1 to BQ for 5min showed
similar protective eﬀects, as 120 μM or higher NADPH concentrations
could reverse the TrxR1 crosslink formation. This phenomenon was
examined further by use of columns to remove excess BQ after pre-
treatment of TrxR1 with BQ, with diﬀerent concentrations of NADPH
then added to the samples. As shown in Fig. 4C, after desalting, con-
centration of NADPH as low as 20 μM NADPH could reverse crosslink
formation, with both an increase in the monomer, and decreases in the
oligomer bands were detected. These results suggest that BQ mod-
iﬁcation do not hinder the NADPH binding to the enzyme, and that
NADPH or NADPH-reduced TrxR1 species can reduce BQ-induced inter-
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molecular disulﬁde bonds between TrxR1 subunits.
3.5. Eﬀect of GSH on BQ-induced TrxR1 inactivation and crosslinks
GSH is the most abundant low-molecular-mass thiol-containing
molecule in cells, and consequently the potential eﬀects of GSH on BQ-
TrxR1 interactions were examined. GSH was either co-incubated with
BQ and TrxR1, or added after reaction of BQ with TrxR1 for 5min. The
samples were then desalted, and residual enzyme activity determined
using both DTNB and juglone as substrates. The results obtained in-
dicate that co-incubation with GSH protects TrxR1 from inactivation by
BQ, both in the presence and absence of NADPH. Adding GSH after pre-
exposure of NADPH-reduced TrxR1 to BQ, did not however, have any
protective eﬀect with regards to the loss of enzyme activity. These data
are consistent with a protective eﬀect of GSH for both the N-terminal
and C-terminal catalytic centres (Fig. 5A and B), and also indicate that
GSH aﬀords protection of TrxR1 activity mainly by competitive reac-
tion with BQ.
To conﬁrm this competitive eﬀect of GSH, co-incubation of GSH at
diﬀerent concentrations (50, 100, 400 μM) with BQ (100 μM) and
TrxR1 (0.8 μM) was performed, followed by analysis with SDS-PAGE as
described above. The results show that co-incubation with GSH con-
centration-dependently decreases BQ-induced crosslinking of TrxR1,
while adding GSH after the reaction initiated does not reverse the
crosslinks (Fig. 5C and D). These results are again consistent with GSH
protecting TrxR1 predominantly by directly scavenging BQ.
3.6. Inactivation of TrxR in J774A.1 cells by BQ
The data presented above demonstrate that BQ can trigger activity
loss in puriﬁed TrxR1, whilst also being a substrate for the enzyme. The
potential relevance of these reactions in more complex systems was
investigated in J774A.1 cells, using both intact cells and cell lysates.
Consistent with the isolated protein studies, BQ induced a concentra-
tion-dependent activity loss of TrxR after only 5min incubation with
lysates prepared from J774A.1 cells, with 40 μM BQ inducing over 90%
loss of activity (Fig. 6A).
With intact cells, BQ also induced a concentration-dependent ac-
tivity loss, but the extent was, as might be expected, diﬀerent to that
observed with the isolated protein and cell lysate. Inactivation was
observed with 40 μM and 80 μM BQ, with 40 μM BQ giving rise to a
50% loss of activity in the intact cells after 5min incubation (Fig. 6B).
4. Discussion
The data obtained in this study indicate that TrxR1 is readily tar-
geted by BQ in the presence of NADPH, resulting in a rapid, con-
centration-dependent, loss of enzyme activity (Figs. 1 and 6). Identical
concentrations of BQ induced a lower extent of loss of activity in intact
J774A.1 cells, when compared to cell lysates, suggesting the cellular
uptake, metabolism and eﬄux processes may be critical in determining
the extent of BQ-TrxR interaction in cells (including GSH scavenging, as
here also found in vitro). The high percentage loss of cellular TrxR ac-
tivity (~90%) induced by BQ may indicate targeting of both TrxR1 and
Fig. 1. BQ induced activity loss of TrxR1. BQ (4 and 100 μM) was incubated with TrxR1 (0.8 μM) with and without NADPH (200 μM) in Tris-EDTA buﬀer (pH 7.6) for
5 min at 22 °C. Samples were desalted using Zeba columns before analysis. Enzyme activity was measured by use of: (A) DTNB, or (B) juglone. #p < 0.05,
##p < 0.01 vs. control group, *p < 0.05, **p < 0.01 vs. without NADPH treatment group.
Fig. 2. BQ-induced Cys and Sec modiﬁcation. TrxR1 (0.8 μM) was incubated with BQ (0–100 μM) with (A) and without (B) NADPH (200 μM) in Tris-EDTA buﬀer (pH
7.6) for 5min at 22 °C. Cys and Sec residues were identiﬁed using BPI labelling. For further details see Materials and methods.
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TxrR2 (the mitochondrial isoform), though no deﬁnitive information
has been obtained on this point. It should, however, be noted that be-
cause TrxR1 is responsible for the majority of the TrxR activity in cells
(as it is present at much higher levels and has a higher catalytic eﬃ-
ciency [24]), it is possible that BQ only targets the TrxR1 isoform.
Further studies are required to clarify this point. The results obtained
demonstrate that the observed BQ-induced inactivation is likely to be
due to direct modiﬁcation of both Sec and Cys residues in isolated
TrxR1 (Fig. 7), as BPI labelling of these residues was decreased on in-
cubation with BQ at both pH 6.5 and 8.5. Similar inhibition eﬀects on
TrxR have been observed with other electrophiles, including 4-hydroxy-
2-nonenal [35] and curcumin [27], two diﬀerent α,β-unsaturated ke-
tone compounds that inhibit both puriﬁed TrxR, and this enzyme in
HeLa cells.
As reported previously, BQ is a substrate of TrxR1, with the enzy-
matic parameters determined in this study (kcat 7.44 ± 0.14 s−1, kcat/
Km 0.91 ± 0.22 μM−1 s−1) similar to those reported earlier (kcat
4.8 ± 0.5 s−1, kcat/Km 0.39 ± 0.1 μM−1 s−1) [20]. However, we have
previously reported that BQ can react rapidly with Cys residues on
proteins, with the rate constant, k, for adduction of BQ to the Cys34
residue in BSA being ~105M−1 s−1 [10]. On the basis of previous data
indicating that the rate constants for reaction of Sec, when compared to
Cys, with electrophiles is typically 2-3 orders of magnitude higher at pH
7.0 [36], and that a similar rate enhancement is seen in oxidant reac-
tions (see, e.g., Refs. [37–39]), it is expected that the rate constant for
adduction of BQ with TrxR1 would also be very fast and signiﬁcantly
greater than 105M−1 s−1, though this needs to be experimentally
veriﬁed. Therefore, in the presence of NADPH, the reactions of BQ with
TrxR1 are complex, with both redox cycling and covalent adduction
reactions occurring, and both processes may contribute to the loss of
enzyme activity.
In the presence of NADPH, BQ did not induce a high level of
crosslinking of TrxR1, with only low levels of (uncharacterized) non-
reducible dimer bands observed. These linkages may be related to the
BQ-induced non-reducible crosslinks observed with other proteins (e.g.,
GAPDH and CK), which have been proposed to contain quinone-
mediated linkages arising from two successive Michael addition reac-
tions [10]. Yu et al. [40] have demonstrated the formation of similar
quinone bridge species as a result of BQ-induced modiﬁcation of an-
nexin V. A previous study has also reported that TrxR1 can form tet-
ramers involving di-Trp (Trp114-Trp114) linkages when subjected to
oxidation [31]. A similar process may also occur here as TrxR1-induced
redox cycling of BQ is likely to generate O2−. and downstream species.
Further characterization of these dimers is therefore required to de-
termine whether these contain quinone-bridge structures, di-Trp lin-
kages, or both.
In contrast to our expectations, BQ could also induce TrxR1 enzyme
activity loss in the absence of NADPH, although the extent was less
marked. BPI labelling experiments indicate that BQ can also modify the
non-catalytic Cys residues in the protein (Fig. 7), and these alterations
Fig. 3. BQ-induced TrxR1 crosslinking for-
mation. TrxR1 (0.8 μM) was incubated with
BQ (0–100 μM) for 5min with or without
NADPH (200 μM) in Tris-EDTA buﬀer (pH
7.6) at 22 °C. Samples were subjected to
SDS-PAGE under (A) non-reducing and (B)
reducing conditions, followed by Coomassie
blue staining. (C) TrxR1 (0.8 μM) was in-
cubated with BQ (0–100 μM), and aliquots
were taken immediately and after 5, 10, 20,
40, and 60min after the initiation of the
reaction, and subjected to SDS-PAGE under
non-reducing and reducing conditions fol-
lowed by Coomassie blue staining. (D,E)
Native TrxR1 (U, 0.8 μM) and mutated
TrxR1 (Sec to Cys, C; Sec to Ser, S, 0.8 μM)
was incubated with BQ (100 μM) in Tris-
EDTA buﬀer (pH 7.6) at 22 °C for 5min
with or without NADPH. Samples were
subjected to SDS-PAGE under (D) non-re-
ducing and (E) reducing conditions fol-
lowed by Coomassie blue staining.
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may be responsible for the detection of high levels of protein crosslinks
under these conditions. The majority of these linkages appear to be due
to the rapid formation of disulﬁde bonds, with oligomer formation
detected immediately after mixing of BQ with TrxR1. In contrast, non-
reducible crosslink formation was slow and could only be detected at
longer incubation times, with this increasing in a time-dependent
manner (Fig. 3C).
In the presence of NADPH, a signiﬁcant loss of the parent TrxR1
monomer band was identiﬁed on exposure to 100 μM BQ (Fig. 3A). This
loss could be reversed by DTT, consistent with the presence of disulﬁde
bonds (Fig. 3B). This may occur via direct thiol-disulﬁde exchange, a
known pathway to disulﬁde-bonded crosslinks [41,42], or via a qui-
none-triggered reaction [43,44]. The latter may be the pathway oper-
ating here, with the presence of NADPH switching disulﬁde bond for-
mation from intermolecular to intramolecular. BQ has been reported
previously to modify Cys residues on proteins in erythrocyte ghost
membranes, with this inducing the formation of high molecular mass
aggregates, and oxidation of epigallocatechin-3-gallate has been shown
to form quinone intermediates that can induce aggregation of mem-
brane proteins [45].
Neither the loss of the parent protein band, nor this aggregation,
was reversed by mutation of the C-terminal Sec (to Cys or Ser; Fig. 3D
and E), indicating that these crosslinks are not related to reaction of BQ
with the C-terminal Sec residue, or the native enzymatic activity of
TrxR1. The observation that the disulﬁde-bonded crosslinks can be re-
duced by NADPH (Fig. 4), also implies that BQ adduction does not
damage the NADPH binding site, or modulates the intra-protein elec-
tron transfer reactions that occur during the catalytic cycle of TrxR1.
As quinones can serve as both redox-cycling substrates and elec-
trophiles with TrxR1, the role of these two pathways in crosslink for-
mation was examined using additional substrates with diﬀerent speci-
ﬁcities. In the absence of NADPH, the alternative quinone, juglone
(which reacts with the N-terminal Cys residues in addition to the C-
terminal Sec-containing active site) induced limited crosslink
formation, which could be repaired by DTT consistent with disulﬁde
generation. In contrast, 9,10-PQ did not induce crosslink formation
(Supplementary Fig. 2). These data are consistent with the electrophilic
properties of quinones being critical to TrxR1 crosslink formation.
Furthermore, auranoﬁn, a well-established TrxR1 inhibitor that binds
irreversibly with Cys and Sec residues [46] did not induce crosslink
formation, suggesting that this is a speciﬁc property of electrophilic
quinones (Supplementary Fig. 2).
GSH has been reported to protect GAPDH against BQ-induced loss of
activity by acting as both a competitive target for BQ (with this re-
sulting in the formation of GSH-BQ adducts), or by acting as a sec-
ondary nucleophile that can react with the initial quinoprotein adduct
via a S-transarylation pathway to repair the protein with consequent
formation of a GSH-BQ adduct [10,47]. In the light of this data, the
protective eﬀect of GSH against loss of TrxR1 activity was also in-
vestigated. Co-incubation with GSH could decrease the extent of BQ-
induced TrxR1 activity loss, while adding GSH after pre-treatment of
the TrxR1 with BQ had no protective eﬀect (Fig. 5A and B). Co-in-
cubation with GSH, but not addition after pre-exposure, also decreased
BQ-induced TrxR1 crosslink formation (Fig. 5). These data suggest that
BQ-induced TrxR1 inactivation is irreversible, and GSH limits BQ-in-
duced damage primarily by acting as a competitive target for BQ.
The extent of BQ-induced damage in vivo is therefore likely to be
dependent on the relative concentrations of GSH versus TrxR (which
will be heavily weighted in favour of GSH), and also the relative rate
constants for reaction of BQ with these two species. We have reported
kinetic data for the GSH reaction (k2 ~ 6×105M−1 s−1 at 10 °C and
pH 7.4 [10]), but the corresponding data for TrxR1 are not available.
However as indicated above, it would be expected that the rate constant
for reaction with the protein would have a higher value due to the
greater nucleophilicity of the selenite anion (RSe−) compared to the
(neutral) thiol of GSH. Whether this greater reactivity outweighs the
concentration diﬀerence remains to be established, but it is clear that
TrxR1 can still be inhibited in a cellular context. Hence, we propose
Fig. 4. Eﬀect of NADPH on BQ-induced TrxR1
crosslinking formation. (A) TrxR1 (0.8 μM) was in-
cubated with BQ (100 μM) and various NADPH
concentrations (0–400 μM) for 5 min. (B,C) TrxR1
(0.8 μM) was incubated with BQ (100 μM) for 5min,
then NADPH (0–200 μM) was added directly (B) or
after desalting using Zeba columns (C) with further
incubation for another 5min. Samples were sub-
jected to SDS-PAGE under non-reducing (A, B, and
C) and reducing conditions (A) followed by
Coomassie blue staining.
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that GSH is likely to be the major target, but that due to the high re-
activity of TrxR1 (and possibly TrxR2), enzyme inactivation will still
occur. The non-reversibility of BQ adduction and hence loss of enzyme
activity may have a cumulative eﬀect in cells, especially if exposure to
BQ (or other quinones) is at a signiﬁcant level and chronic (e.g. via
ongoing environmental exposure, or as a result of long-term drug
treatment).
TrxR is critical to the cellular Trx antioxidant system, and together
Fig. 5. Eﬀect of GSH on BQ-induced TrxR1 activity loss and crosslinking formation. (A, B) TrxR1(0.8 μM) was incubated with BQ (100 μM) with or without NADPH
(200 μM) in Tris-EDTA buﬀer (pH 7.6) at 22 °C. GSH (400 μM) was added at the same time (CG) or 5min after the initiation and incubated for a further 5 min (AG).
Samples were desalted by column chromatography followed by assessment of activity using (A) DTNB, or (B) juglone. (C, D) TrxR1(0.8 μM) was incubated with BQ
(100 μM) without (C) or with (D) NADPH (200 μM) for 5min in Tris-EDTA buﬀer (pH 7.6) at 22 °C, GSH (0–400 μM) was added at the same time or 5min after the
initiation of the reaction, and incubated for a further 5min. Samples were subjected to SDS-PAGE under non-reducing conditions followed by Coomassie blue
staining. #p < 0.05, ##p < 0.01 vs. control group, *p < 0.05, **p < 0.01 vs. BQ treatment group.
Fig. 6. Inhibition of TrxR by BQ in J774A.1 cell lysate (A) and intact cells (B). J774A.1 cell lysates from 1×106 cells, or intact cells (1× 106) were incubated with
the indicated concentrations of BQ for 5 min. Residual TrxR activity was then analysed using DTNB as the substrate. For further details see Materials and methods.
*p < 0.05, **p < 0.01 vs. control (CON) samples with no added BQ.
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with the GSH/GPx/GR/NADPH antioxidant system maintains cellular
redox homeostasis. The TrxR/Trx system has also been shown to be
involved in additional physiological and pathological processes in-
cluding cell death pathways [48], cancer [49], inﬂammation [50], and
neurodegenerative disease [51]. Moreover, inhibition of this system,
and especially TrxR activity, has been strongly associated with the cy-
totoxic eﬀects of multiple compounds including 4-hydroxy-2-nonenal
[35], ﬂavonoids [28], and arsenic trioxide [52]. Trx, the substrate of
TrxR, can also serve as the negative regulator to suppress the activation
of apoptosis signal-regulating kinase (ASK1) [53]. Therefore, inhibition
of TrxR may lead to the accumulation of oxidised Trx, and result in the
activation of ASK1 and cell apoptosis. Previous research has also de-
monstrated that indolequinone can inactivate TrxR in MIA PaCa-2 cells,
which results in increased levels of oxidised Trx, activation of the ASK1-
p38/c-Jun NH2-terminal kinase (JNK) mitogen-activated protein kinase
(MAPK) signalling pathway and cell apoptosis [54]. The inhibition of
TrxR activity by BQ in the J774A.1 cells studied here suggests that the
activation of the ASK1-MAPK signalling pathway and cell apoptosis
may also be triggered in these cells. Preliminary studies suggest that
this is correct (Shu, N. et al., unpublished data). This study therefore
provides a new insight into the potential biological targets of BQ, and
provides a potential new mechanism for BQ-induced cell apoptosis.
As summarized in Fig. 7, this study demonstrates that BQ can irre-
versibly modify the Sec residue of TrxR1 resulting in a loss of enzyme
activity in the presence of NADPH. GSH can protect against this activity
loss when present concurrently with TrxR1, but not after damage has
already been induced by BQ. This occurs primarily through competitive
reaction with BQ. In the absence of NADPH, BQ can modify the non-
catalytic Cys residues of TrxR1, leading to crosslink formation, with
these modiﬁcations being reversible and also modulated by GSH. These
results provide new insights into cytotoxicity mechanisms of BQ.
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